Rallybio Corporation - fluxo de caixa trimestral (NASDAQ:RLYB) | MetaTrader

Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas

Cash from operating activities -9.86 M-10.21 M-8.38 M-6.55 M-4.68 M -29.81 M Cash from investing activities -1.57 M11.08 M3.04 M29.23 M3.92 M 47.27 M Cash from financing activities 18 K010 K06 000 16 K Free cash flow -9.86 M-10.21 M-8.38 M-6.55 M-4.68 M -29.81 M

Notícias

Diretor médico da Rallybio deixa a empresa em mudança de liderança

Rallybio Corporation (RLYB) M&A Call Prepared Remarks Transcript

Rallybio vai adquirir Candid Therapeutics em acordo de US$ 505 milhões

Rallybio to acquire Candid Therapeutics in $505M deal

Tiny Biotech Rallybio Stock Surges As $500 Million-Backed Merger Fuels Investor Optimism - Rallybio (NASDAQ:RLYB)

CFO da Rallybio vende US$ 3.992 em ações

Lieber, Rallybio CFO, sells $3992 in shares

Rallybio reports positive phase 1 results for subcutaneous C5 inhibitor

Rallybio announces one-for-eight reverse stock split effective Feb 6

Upcoming Stock Splits This Week (February 2 to February 6) – Stay Invested - TipRanks.com

Rallybio implementará desdobramento reverso de ações de 1 para 8 a partir de 6 de fevereiro

Rallybio to implement 1-for-8 reverse stock split effective February 6